Medicare P&Ts Would Follow Pharmacist Groups’ Principles Under CMS Draft
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacy & therapeutics committee principles developed by the American Society of Health System Pharmacists and Academy of Managed Care Pharmacy will serve as guidelines for Part D drug plans, CMS draft formulary guidelines say. The guidelines also list standards CMS will use in approving formularies.
You may also be interested in...
USP's Finalized Model For Medicare Rx Formularies Retains 146 Drug Groups
Overall, the model guidelines resemble the version proposed by USP in August but include revisions to specific therapeutic categories and pharmacologic classes. Proton pump inhibitors are placed in a separate drug class; SSRIs/SNRIs remain off the formal chart.
USP's Finalized Model For Medicare Rx Formularies Retains 146 Drug Groups
Overall, the model guidelines resemble the version proposed by USP in August but include revisions to specific therapeutic categories and pharmacologic classes. Proton pump inhibitors are placed in a separate drug class; SSRIs/SNRIs remain off the formal chart.
USP Submits Final Medicare Model Formulary Guidelines
U.S. Pharmacopeia submitted its final version of the Medicare model formulary guidelines to the Centers for Medicare & Medicaid Services for review Dec. 10